Client News

seragy Launches with €12 Million Financing to Advance Quantitative Biomarkers for Neurodegenerative Diseases

AL-S Pharma Appoints Harry Welten as Chief Executive Officer

NVision Deploys POLARIS at UCLouvain to Advance Cancer Metabolism Research

PL BioScience Launches PL Synergy to Simplify and Standardize MSC Research

Formycon and Zydus: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by FDA

Newron Provides Update on FDA Clinical Hold and Phase 3 ENIGMA-TRS Development Program 

InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026

Formycon Optimizes Biosimilar Development with AI-Powered Technologies: Digital Solutions Enhance Development Efficiency as Part of the FYB4GROWTH Strategy

Fierce Biotech Names ReproNovo A “Fierce 15” Company Of 2026

iOmx Therapeutics Appoints Rüdiger Wolff as Chief Financial Officer